
IndraLab
Statements
USP8 activates cell population proliferation. 37 / 37
|
37
reach
"As USP8 silencing significantly inhibited the PCa cell growth, proliferation, and metastasis and induced apoptosis and suppressed NF-kB signal activation by decreasing EGFR and PI3K, the USP8-specific inhibitor might be a novel therapeutic target to suppress PCa cell growth, proliferation, and metastasis."
reach
"Mass spectrometry and RNA pull-down assays showed that piR-1742 can directly bind to the hnRNPU protein to form a complex.To the best of our knowledge, this is the first work to elucidate that abundantly expressed piR-1742 might act as a critical mediator in the activation of USP8/MUC12 signaling, hence enhancing the proliferation of RCC cells while also promoting RCC invasion and metastasis."
reach
"Moreover, we found that USP8 deficiency inhibited pancreatic tumor proliferation and extended overall survival by improving anti-tumor immunogenicity.The most crucial issue in anti-tumor treatment is fixing the therapeutic targets, and increasing studies report that immune checkpoint blockade (ICB) can stimulate the immune system using PD-L1 antibodies, while tumor cells often resist anti-PD-L1 therapy via immune evasion."
reach
"We will provide an overview of corticotroph tumorigenesis in the context of hypothalamic-pituitary-adrenal (HPA) axis regulation with an emphasis on the role of the glucocorticoid receptor in the resistance to the negative feedback of cortisol that occurs in CD, and we will explore the role of epidermal growth factor receptor (EGFR) signaling in ACTH hyper-secretion and corticotroph cell proliferation and the recent discovery of somatic ubiquitin specific peptidase 8 (USP8) mutations in a significant number of patients with sporadic CD with an emphasis on therapeutic implications."
reach
"Indeed, inhibition of USP8 either by its knockdown or synthetic small molecule led to attenuation of variety of receptor tyrosine kinase (RTK) activities, resulting in the inhibition of cell proliferation in gefitinib resistant and -sensitive non small cell lung cancer (NSCLC) cells [XREF_BIBR]."